These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18287021)

  • 1. Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function.
    Marcondes AM; Mhyre AJ; Stirewalt DL; Kim SH; Dinarello CA; Deeg HJ
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):2865-70. PubMed ID: 18287021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
    Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.
    Li X; Marcondes AM; Gooley TA; Deeg HJ
    Blood; 2010 Sep; 116(13):2304-14. PubMed ID: 20562331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Cull AH; Mahendru D; Snetsinger B; Good D; Tyryshkin K; Chesney A; Ghorab Z; Reis M; Buckstein R; Wells RA; Rauh MJ
    Leuk Res; 2018 Feb; 65():5-13. PubMed ID: 29227812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [IL-32 mRNA Expression of Bone Marrow Stromal Cells and Its Correlation with Cell Apoptosis in Patients with Myelodysplastic Syndrome].
    Zhang YY; Xu L; Li DQ; Shao JH; Chen P; Zhao HY; Dong XB; Gu LP; Wu W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):773-8. PubMed ID: 27342508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD.
    Mhyre AJ; Marcondes AM; Spaulding EY; Deeg HJ
    Blood; 2009 Jan; 113(3):649-58. PubMed ID: 18945969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
    Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
    Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Bone Marrow Natural Killer Cells (NK); Soluble TNF-α and IL-32 Levels in Myelodysplastic Syndrome Patients.
    Aref S; Khaled N; Al Gilany AH; Ayed M; Abouzeid T; Attia D
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2949-2953. PubMed ID: 33112553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
    Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
    Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
    Wu LY; Li X; Chang CK; Ying SX; Pu Q
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes.
    Zhang Z; Li X; Guo J; Xu F; He Q; Zhao Y; Yang Y; Gu S; Zhang Y; Wu L; Chang C
    Eur J Haematol; 2013 May; 90(5):375-84. PubMed ID: 23331180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS.
    Marcondes AM; Ramakrishnan A; Deeg HJ
    Curr Cancer Ther Rev; 2009 Nov; 5(4):310-314. PubMed ID: 20305828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia.
    Wetzler M; Kurzrock R; Estrov Z; Estey E; Talpaz M
    Leuk Res; 1995 Jan; 19(1):23-34. PubMed ID: 7837815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.
    Chamseddine AN; Cabrero M; Wei Y; Ganan-Gomez I; Colla S; Takahashi K; Yang H; Bohannan ZS; Garcia-Manero G
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S67-73. PubMed ID: 27521329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.
    Bellamy WT; Richter L; Sirjani D; Roxas C; Glinsmann-Gibson B; Frutiger Y; Grogan TM; List AF
    Blood; 2001 Mar; 97(5):1427-34. PubMed ID: 11222390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subtype and Functional Biomarker Changes of NK Cells in Peripheral Blood of Patients with Myelodysplastic Syndrome].
    Xu SJ; Shao ZH; Fu R; Wang HQ; Liu H; Liu CY; Zhang W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):832-836. PubMed ID: 28641645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome.
    Carlsten M; Baumann BC; Simonsson M; Jädersten M; Forsblom AM; Hammarstedt C; Bryceson YT; Ljunggren HG; Hellström-Lindberg E; Malmberg KJ
    Leukemia; 2010 Sep; 24(9):1607-16. PubMed ID: 20613786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes.
    Kiladjian JJ; Bourgeois E; Lobe I; Braun T; Visentin G; Bourhis JH; Fenaux P; Chouaib S; Caignard A
    Leukemia; 2006 Mar; 20(3):463-70. PubMed ID: 16408099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?
    Stirewalt DL; Mhyre AJ; Marcondes M; Pogosova-Agadjanyan E; Abbasi N; Radich JP; Deeg HJ
    Br J Haematol; 2008 Feb; 140(4):444-53. PubMed ID: 18162123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.
    Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE
    Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.